Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MIR200C and MIR141 host gene (MIR200CHG) is a non-coding RNA gene locus that gives rise to the microRNAs miR-200c and miR-141. This locus forms the miR-200c/miR-141 intergenic cluster on chromosome 12, spanning regions crucial for epithelial cell identity, epithelial-mesenchymal transition (EMT), stress response, and tumorigenesis. The primary transcript undergoes complex regulation involving DNA looping and transcriptional co-regulation with the nearby PTPN6 gene (SHP1), affecting cellular response to oxidative stress and tumorigenic stimuli[2][1]. Deregulation of miR-200c/miR-141 expression influences cancer progression, metastasis, chemosensitivity, and tissue development. While this locus itself is not a direct therapeutic target, the mature miRNAs it hosts are functional regulators with disease significance and therapeutic interest[1][2][4].
Not applicable for MIR200CHG itself; for miR-200c/miR-141, mechanisms include modulation of gene expression by binding target mRNAs and repressing translation (microRNA-mediated silencing)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR200C and MIR141 host gene (MIR200CHG).